Regenerex Pharma (RGPX) Other Operating Expenses (2010 - 2025)
Regenerex Pharma (RGPX) reported Other Operating Expenses of $538618.0 for Q1 2025, up 30.0% year-over-year from $414325.0 in Q1 2024, and up 30.0% quarter-over-quarter from $414325.0 in Q1 2024.
Regenerex Pharma (RGPX) Other Operating Expenses (2010 - 2025) Analysis & Trends
Regenerex Pharma (RGPX) has 9 years of Other Operating Expenses data on file, last reported at $538618.0 in Q1 2025.
- Other Operating Expenses for Q1 2025 came in at $538618.0, up 30.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $538618.0 (up 30.0% YoY), and the FY2025 annual result was $538618.0, up 30.0% from the prior year.
- Other Operating Expenses improved to $538618.0 in Q1 2025 per RGPX's latest filing, from $414325.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $538618.0 in Q1 2025 and troughed at $414325.0 in Q1 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 538,618.00 |
| Mar 31, 2024 | 414,325.00 |
| Dec 31, 2020 | 1,966.00 |
| Sep 30, 2020 | 234.00 |
| Jun 30, 2020 | 856.00 |
| Mar 31, 2020 | 765.00 |
| Dec 31, 2019 | 1,570.00 |
| Sep 30, 2019 | 237.00 |
| Jun 30, 2019 | 14,296.00 |
| Mar 31, 2019 | -300.00 |
| Nov 30, 2014 | -388,325.00 |
| Aug 31, 2014 | 4,426.00 |
| Nov 30, 2013 | -736,097.00 |
| Aug 31, 2013 | 238,758.00 |
| Feb 28, 2013 | 240,693.00 |
| Nov 30, 2012 | 492,546.00 |
| Aug 31, 2012 | 7,468.00 |
| Feb 29, 2012 | 141,989.00 |
| Nov 30, 2011 | 184,745.00 |
| Aug 31, 2011 | 15,851.00 |